GARS antibody (AA 35-305)
-
- Target See all GARS Antibodies
- GARS (Glycyl-tRNA Synthetase (GARS))
-
Binding Specificity
- AA 35-305
-
Reactivity
- Human
-
Host
- Mouse
-
Clonality
- Monoclonal
-
Conjugate
- This GARS antibody is un-conjugated
-
Application
- Western Blotting (WB)
- Predicted Reactivity
- Human
- Immunogen
- Recombinant human GARS between 35-305 amino acids.
- Clone
- A2S3
- Top Product
- Discover our top product GARS Primary Antibody
-
-
- Application Notes
- WB 1:300-5000
- Restrictions
- For Research Use only
-
- Concentration
- 0.5 μg/μL
- Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
- Preservative
- ProClin
- Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Storage
- 4 °C,-20 °C
- Storage Comment
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
- Expiry Date
- 12 months
-
- Target
- GARS (Glycyl-tRNA Synthetase (GARS))
- Alternative Name
- GARS (GARS Products)
- Background
-
Synonyms: AP 4 A synthetase, Charcot Marie Tooth neuropathy 2D, Charcot Marie Tooth neuropathy neuronal type D, CMT2D, Diadenosine tetraphosphate synthetase, DSMAV, EC 6.1.1.14, Glycine tRNA ligase, Glycyl tRNA synthetase, GlyRS, HMN5, SMAD1, GARS_HUMAN.
Background: GARS synthetase catalyzes the ligation of glycine with glycyl-tRNA using ATP and its mutation induces Charcot-Marie-Tooth (CMT) disease.
- Gene ID
- 2617
- UniProt
- P41250
- Pathways
- Ribonucleoside Biosynthetic Process
-